Skip to Content
MIT News: 77 Mass Ave

GI trouble? Swallow this sensor.

A pill that transmits its location in the digestive system could point doctors to trouble spots.

April 25, 2023
Capsule on a United States quarter to show its length is the same as the coin's diameter
Courtesy of the Researchers

About 35 million Americans suffer from digestive issues such as constipation, gastroesophageal reflux disease, and gastroparesis (partial stomach paralysis). These so-called motility disorders, in which food fails to move through the system properly, are often diagnosed using endoscopy, nuclear imaging studies, or x-rays. 

But engineers at MIT and Caltech have come up with a less invasive alternative: an ingestible sensor whose location can be monitored on its trip through the body. The innovation could someday make it much easier to pinpoint the source of the trouble without a hospital visit. In a new study, the researchers showed that they could use their system to track the sensor as it moved through the digestive tract of large animals. 

The tiny sensor measures a magnetic field produced by an electromagnetic coil outside the body. Its progress can be calculated from the measurements because the field’s strength weakens with distance from the coil. The hope is that doctors could use this information to determine what part of the digestive tract is causing a slowdown and help decide on a treatment.

The small capsule measures a magnetic field produced by a coil outside the body, making it possible to track its position in the GI tract.

To help pinpoint the swallowed pill’s location, a second sensor remains outside the body as a reference point. This sensor could be taped to the skin, while the coil could be placed in a pocket or backpack, or even on the back of a toilet. A wireless transmitter sends the magnetic field measurement to a nearby computer or smartphone. 

“The ability to characterize motility without the need for radiation, in-hospital visits, or more invasive placement of devices could lower the barrier for people to be evaluated,” says Giovanni Traverso, a senior author of the study, who is an associate professor of mechanical engineering at MIT and a gastroenterologist at Brigham and Women’s Hospital. The researchers now hope to work with collaborators on manufacturing processes and eventually to test the system in humans. 

Keep Reading

Most Popular

DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.

“This is a profound moment in the history of technology,” says Mustafa Suleyman.

What to know about this autumn’s covid vaccines

New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.

Human-plus-AI solutions mitigate security threats

With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure

Next slide, please: A brief history of the corporate presentation

From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at with a list of newsletters you’d like to receive.